BridgeBio (NASDAQ: BBIO) awards RSUs and stock options to director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BridgeBio Pharma, Inc. director Ellis Andrea reported receiving new equity awards. On June 22, 2026, Ellis was granted 3,990 restricted stock units that vest in full on June 22, 2027, subject to continued board service. Each RSU represents one share of common stock.
Ellis was also granted a stock option covering 5,277 shares of common stock at an exercise price of $68.92 per share, expiring on June 21, 2036, with all option shares vesting on June 22, 2027. Following these awards, Ellis directly holds 22,579 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Ellis Andrea
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,277 | $0.00 | -- |
| Grant/Award | Common Stock | 3,990 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,277 shares (Direct);
Common Stock — 22,579 shares (Direct)
Footnotes (1)
- Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.
Key Figures
RSU grant size: 3,990 RSUs
Option grant size: 5,277 shares
Option exercise price: $68.92 per share
+3 more
6 metrics
RSU grant size
3,990 RSUs
Granted June 22, 2026; vest June 22, 2027
Option grant size
5,277 shares
Stock option (right to buy) granted June 22, 2026
Option exercise price
$68.92 per share
Exercise price for 5,277-share stock option
Option expiration
June 21, 2036
Expiration date of stock option
Common shares held
22,579 shares
Total common stock directly held after transactions
Vesting date
June 22, 2027
Full vesting date for RSUs and option shares
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), vest in full, contingent right, +1 more
5 terms
restricted stock units ("RSUs") financial
"Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
vest in full financial
"The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service"
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."
exercise price financial
"conversion_or_exercise_price": "68.9200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What equity awards did BridgeBio (BBIO) director Ellis Andrea receive?
Director Ellis Andrea received 3,990 restricted stock units and a stock option for 5,277 shares. Both awards were granted on June 22, 2026, as part of BridgeBio Pharma’s equity incentive compensation for board service.
When do Ellis Andrea’s BridgeBio (BBIO) RSUs and options vest?
Both the 3,990 RSUs and the option for 5,277 underlying shares vest in full on June 22, 2027. Vesting is contingent on Ellis Andrea’s continued service on BridgeBio Pharma’s board of directors through that date.
What is the exercise price and expiration date of Ellis Andrea’s BridgeBio option?
The stock option granted to Ellis Andrea has an exercise price of $68.92 per share and expires on June 21, 2036. It covers 5,277 underlying common shares, which all vest together on June 22, 2027.
What do the BridgeBio RSUs granted to Ellis Andrea represent?
Each restricted stock unit granted to Ellis Andrea represents a contingent right to receive one share of BridgeBio common stock. The 3,990 RSUs will settle into shares once they vest on June 22, 2027, assuming continued service on the board.